A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple Myeloma

A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple Myeloma

Multiple myeloma (MM) is the second most common hematological malignancy, arising from terminally differentiated B cells, namely plasma cells. miRNAs are small non-coding RNAs that participate in the post-transcriptional regulation of gene expression. In this study, we investigated the role of nine...

Full description

Bibliographic Details
Main Authors: Aristea-Maria Papanota, Paraskevi Karousi, Christos K. Kontos, Pinelopi I. Artemaki, Christine-Ivy Liacos, Maria-Alexandra Papadimitriou, Tina Bagratuni, Evangelos Eleutherakis-Papaiakovou, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Efstathios Kastritis, Margaritis Avgeris, Meletios-Athanasios Dimopoulos, Andreas Scorilas, Evangelos Terpos
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:International Journal of Molecular Sciences
Subjects:
miRNA
small non-coding RNA (sncRNA)
plasma cell dyscrasias
multiple myeloma bone disease (MMBD)
post-transcriptional regulation
target mRNA
Online Access:https://www.mdpi.com/1422-0067/22/23/13144

Internet

https://www.mdpi.com/1422-0067/22/23/13144

Similar Items